CM
MGNX icon

Caption Management’s MacroGenics MGNX Stock Holding History

Caption Management’s Portfolio MGNX Stock Details MGNX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-75,000
Closed -$2.39M – 1478
2021
Q1 		$2.39M Buy
+75,000
New +$1.82M 0.05% 463
2019
Q3 		– Sell
-66,900
Closed -$1.14M – 824
2019
Q2 		$1.14M Hold
66,900
– – 0.06% 346
2019
Q1 		$1.2M Buy
+66,900
New +$1.16M 0.07% 311

Other funds holding MGNX

BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
FLSM
Frazier Life Sciences Management Palo Alto, California $3.89B AUM 201.1% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
PA
Pinnacle Associates New York $7.78B AUM 45.07% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Caption Management's MGNX Position: Q3 2024 in Review

Caption Management sold out of MacroGenics (MGNX) in Q3 2024, closing a stake of 34,400 shares — an estimated $146K sold.

Caption Management first reported a position in MGNX in Q1 2019 and held it in 10 quarters. The position peaked at $3.15M in Q1 2021. 124 funds tracked by Wall St. Rank hold MGNX as of Q3 2024.

  • Caption Management reported no remaining MacroGenics position as of Q3 2024 after selling out during the quarter.
  • Caption Management sold 34,400 MacroGenics shares in Q3 2024, an estimated $146K.
  • Caption Management first reported a position in MacroGenics in Q1 2019 and held it in 10 quarters.
  • Caption Management's MacroGenics position peaked at $3.15M in Q1 2021.
  • 124 funds tracked by Wall St. Rank held MacroGenics as of Q3 2024.

Based on Caption Management's 13F filing for Q3 2024, filed 14 Nov 2024.